期刊文献+

Three new lignan glucosides from the roots of Scutellaria baicalensis 被引量:2

Three new lignan glucosides from the roots of Scutellaria baicalensis
原文传递
导出
摘要 Three new lignan glucosides, baicalensinosides A–C(1–3), were isolated from the roots of Scutellaria baicalensis. The structural elucidation was achieved by in-depth spectroscopic examinations and qualitative chemical test. Structurally, these compounds belong to the 3,4-dibenzyltetrahydrofurantype lignan glycoside with a mono-hydroxyl substitution at the 70-position of benzylidene group on the numbering system of lignans being one of their shared critical features. The anti-osteoporotic activity of the isolated compounds was assessed in an in vitro osteoprotegerin(OPG) transcriptional activity assay using dual luciferase reporter detection. At 10 μmol/L, compounds 1–3 increased the relative activating ratio of OPG transcription to 1.83, 0.84 and 0.98 times that of the control group, respectively. Three new lignan glucosides, baicalensinosides A-C (1-3), were isolated from the roots of Scutellaria baicalensis. The structural elucidation was achieved by in-depth spectroscopic examinations and qualitative chemical test. Structurally, these compounds belong to the 3,4-dibenzyltetrahydrofuran-type lignan glycoside with a mono-hydroxyl substitution at the 7'-position of benzylidene group on the numbering system of lignans being one of their shared critical features. The anti-osteoporotic activity of the isolated compounds was assessed in an in vitro osteoprotegerin (OPG) transcriptional activity assay using dual luciferase reporter detection. At 10 mu mol/L, compounds 1-3 increased the relative activating ratio of OPG transcription to 1.83, 0.84 and 0.98 times that of the control group, respectively. (C) 2016 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.
出处 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2016年第3期229-233,共5页 药学学报(英文版)
基金 supported by grants from National Natural Science Foundation of China(No.81361138020)
关键词 SCUTELLARIA baicalensis Roots LABIATAE Lignan GLUCOSIDE Baicalensinosides A–C 3 4-Dibenzyltetrahydrofuran Osteoprotegerin-activating ACTIVITY Anti-osteoporotic ACTIVITY Scutellaria baicalensis Roots Labiatae Lignan glycoside Baicalensinosides A-C 3,4-Dibenzyltetrahydrofuran Osteoprotegenn-activating activity Anti-osteoporotic activity
  • 相关文献

参考文献1

二级参考文献25

  • 1Paul D. Miller.Denosumab: Anti-RANKL antibody[J]. Current Osteoporosis Reports . 2009 (1)
  • 2M. Martinis,M. C. Benedetto,L. P. Mengoli,L. Ginaldi.Senile osteoporosis: Is it an immune-mediated disease?[J]. Inflammation Research . 2006 (10)
  • 3J. Padagas,M. Colloton,V. Shalhoub,P. Kostenuik,S. Morony,L. Munyakazi,M. Guo,D. Gianneschi,E. Shatzen,Z. Geng,H.-L. Tan,C. Dunstan,D. Lacey,D. Martin.The Receptor Activator of Nuclear Factor-κB Ligand Inhibitor Osteoprotegerin Is a Bone-Protective Agent in a Rat Model of Chronic Renal Insufficiency and Hyperparathyroidism[J]. Calcified Tissue International . 2006 (1)
  • 4Olafur S. Indridason,Leifur Franzson,Gunnar Sigurdsson.Serum osteoprotegerin and its relationship with bone mineral density and markers of bone turnover[J]. Osteoporosis International . 2005 (4)
  • 5Simonet SW,Lacey DI,Dunstan CR,et al.Osteoprotegerin: a novel secreted protein involved in the regulation of density. Cell . 1997
  • 6Anderson DM,Maraskovsky E,Billingsley WL,et al.A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature . 1997
  • 7Hofbauer LC,Khosla S,Dunstan CR,et al.Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells. The Journal of Endocrinology . 1999
  • 8Eghbali-Fatourechi G,Khosla S,Sanyal A,et al.Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. The Journal of Clinical Investigation . 2003
  • 9Vidal ON,Brandstorm H,Jonsson KB,et al.Osteoprotegerin mRNA is expressed in primary human osteoblast-like cells: down-regulation by glucocorticoids. Journal of Endocrinology, The . 1998
  • 10Sasaki N,Kusano E,Ando Y,et al.Changes in osteoprotegerin and markers of bone metabolism during glucocorticoid treatment in patients with chronic glomerulonephritis. Bone . 2002

共引文献3

同被引文献64

引证文献2

二级引证文献133

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部